Whitehawk Therapeutics (WHWK) Other Working Capital Changes (2010 - 2025)
Whitehawk Therapeutics (WHWK) reported Other Working Capital Changes of $817000.0 for Q3 2025, up 556.42% year-over-year from $124462.1 in Q3 2024, and up 200.0% on a QoQ basis from -$817000.0 in Q2 2025.
Whitehawk Therapeutics (WHWK) has 15 years of Other Working Capital Changes data on file, last reported at $817000.0 in Q3 2025.
- Quarterly Other Working Capital Changes rose 556.42% year-over-year to $817000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$89000.0 (up 82.62% YoY) and the FY2025 annual result came in at $518706.0, up 201.31% from the prior year.
- Other Working Capital Changes rose to $817000.0 in Q3 2025 per WHWK's latest filing, from -$817000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.1 million in Q4 2024 and bottomed at -$1.9 million in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$55000.0 (2022), against an average of -$80157.9.
- Peak annual rise in Other Working Capital Changes reached 57800.0% in 2022, while the deepest fall reached 23262.5% in 2022.
- Tracing WHWK's Other Working Capital Changes over 5 years: stood at -$8000.0 in 2021, then slumped by 23262.5% to -$1.9 million in 2022, then surged by 73.14% to -$502000.0 in 2023, then jumped by 517.13% to $2.1 million in 2024, then tumbled by 60.98% to $817000.0 in 2025.
- Per Business Quant, the three latest WHWK Other Working Capital Changes figures stand at $817000.0 (Q3 2025), -$817000.0 (Q2 2025), and -$89000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 817,000.00 |
| Sep 30, 2025 | 817,000.00 |
| Jun 30, 2025 | -817,000.00 |
| Jun 30, 2025 | -817,000.00 |
| Mar 31, 2025 | -89,000.00 |
| Mar 31, 2025 | -89,000.00 |
| Dec 31, 2024 | 2.09 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | -179,000.00 |
| Sep 30, 2024 | -179,000.00 |
| Jun 30, 2024 | -1.47 Mn |
| Jun 30, 2024 | -1.47 Mn |
| Mar 31, 2024 | -953,000.00 |
| Mar 31, 2024 | -953,000.00 |
| Dec 31, 2023 | -502,000.00 |
| Dec 31, 2023 | -502,000.00 |
| Sep 30, 2023 | 845,000.00 |
| Sep 30, 2023 | 845,000.00 |
| Jun 30, 2023 | -1.49 Mn |
| Jun 30, 2023 | -1.49 Mn |
| Mar 31, 2023 | 642,000.00 |
| Mar 31, 2023 | 642,000.00 |
| Dec 31, 2022 | -1.87 Mn |
| Dec 31, 2022 | -1.87 Mn |
| Sep 30, 2022 | 1.05 Mn |
| Sep 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | -55,000.00 |
| Jun 30, 2022 | -55,000.00 |
| Mar 31, 2022 | 579,000.00 |
| Mar 31, 2022 | 579,000.00 |
| Dec 31, 2021 | -8,000.00 |
| Dec 31, 2021 | -8,000.00 |
| Sep 30, 2021 | -33,000.00 |
| Sep 30, 2021 | -33,000.00 |
| Jun 30, 2021 | -89,000.00 |
| Jun 30, 2021 | -89,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | -51,000.00 |
| Dec 31, 2020 | -51,000.00 |
| Sep 30, 2020 | 345,704.00 |
| Sep 30, 2020 | 345,704.00 |
| Jun 30, 2020 | -324,417.00 |
| Jun 30, 2020 | -324,417.00 |
| Mar 31, 2020 | -167,287.00 |
| Mar 31, 2020 | -167,287.00 |
| Dec 31, 2019 | -141,707.00 |
| Dec 31, 2019 | -141,707.00 |
| Sep 30, 2019 | 612,187.00 |
| Sep 30, 2019 | 612,187.00 |
| Jun 30, 2019 | -271,869.00 |
| Jun 30, 2019 | -271,869.00 |
| Mar 31, 2019 | -79,507.00 |
| Mar 31, 2019 | -79,507.00 |
| Dec 31, 2018 | -279,410.00 |
| Dec 31, 2018 | -279,410.00 |
| Sep 30, 2018 | -18.09 Mn |
| Sep 30, 2018 | -18.09 Mn |
| Jun 30, 2018 | 18.59 Mn |
| Jun 30, 2018 | 18.59 Mn |
| Mar 31, 2018 | 75,365.00 |
| Mar 31, 2018 | 75,365.00 |
| Dec 31, 2017 | -547,870.00 |
| Dec 31, 2017 | -547,870.00 |
| Sep 30, 2017 | 434,676.00 |
| Sep 30, 2017 | 434,676.00 |
| Jun 30, 2017 | -114,954.00 |
| Jun 30, 2017 | -114,954.00 |
| Mar 31, 2017 | 337,174.00 |
| Mar 31, 2017 | 337,174.00 |
| Dec 31, 2016 | -30,566.00 |
| Dec 31, 2016 | -30,566.00 |
| Sep 30, 2016 | 200,100.00 |
| Sep 30, 2016 | 200,100.00 |
| Jun 30, 2016 | -45,898.00 |
| Jun 30, 2016 | -45,898.00 |
| Mar 31, 2016 | -214,040.00 |
| Mar 31, 2016 | -214,040.00 |
| Dec 31, 2014 | -5,000.00 |
| Dec 31, 2014 | -5,000.00 |
| Jun 30, 2014 | 625.00 |
| Jun 30, 2014 | 625.00 |
| Mar 31, 2014 | 1,875.00 |
| Mar 31, 2014 | 1,875.00 |
| Dec 31, 2013 | 125.00 |
| Dec 31, 2013 | 125.00 |
| Sep 30, 2013 | 4,375.00 |
| Sep 30, 2013 | 4,375.00 |
| Jun 30, 2013 | -1,125.00 |
| Jun 30, 2013 | -1,125.00 |
| Mar 31, 2013 | -2,375.00 |
| Mar 31, 2013 | -2,375.00 |
| Dec 31, 2012 | -4,375.00 |
| Dec 31, 2012 | -4,375.00 |
| Sep 30, 2012 | -375.00 |
| Sep 30, 2012 | -375.00 |
| Jun 30, 2012 | 5,625.00 |
| Jun 30, 2012 | 5,625.00 |
| Mar 31, 2012 | -1,875.00 |
| Mar 31, 2012 | -1,875.00 |
| Dec 31, 2011 | -1,875.00 |
| Dec 31, 2011 | -1,875.00 |
| Sep 30, 2011 | -1,875.00 |
| Sep 30, 2011 | -1,875.00 |
| Jun 30, 2011 | 5,625.00 |
| Jun 30, 2011 | 5,625.00 |
| Mar 31, 2011 | -1,875.00 |
| Mar 31, 2011 | -1,875.00 |
| Dec 31, 2010 | -1,250.00 |
| Dec 31, 2010 | -1,250.00 |
| Sep 30, 2010 | -1,875.00 |
| Sep 30, 2010 | -1,875.00 |